Swigert Anna, Majidian Mandy, Chen Lauren, Vick Garrett, Murina Andrea
All authors are affiliated with the Tulane University School of Medicine Department of Dermatology, New Orleans, Louisiana.
Dermatol Surg. 2022 Jan 1;48(1):17-20. doi: 10.1097/DSS.0000000000003247.
The incarcerated population may have variable access to specialty care that may affect the detection and diagnosis of skin cancer.
The purpose of the study was to characterize skin cancers in the incarcerated population and determine time to treatment initiation (TTI) after biopsy.
A retrospective cohort study was performed using data from a single-center referral hospital of incarcerated patients with biopsy-proven basal cell carcinoma (BCC), squamous cell carcinoma (SCC), or melanoma between January 2009 and December 2019. The main outcome measured was TTI after biopsy.
One hundred thirteen patients, majority men (96.5%) and of Caucasian race (89.4%), were diagnosed and/or treated for 191 skin cancers. Of these 191 skin cancers, 118 were BCC (61.8%), 58 were SCC (30.4%), and 15 were melanomas (7.9%). The average TTI after biopsy for melanoma was 57 days (range: 21-136, median: 51, 95% confidence interval: 39.89-74.10) with an average Breslow depth of 1.57 mm.
The average TTI of melanoma in the incarcerated population in this study was greater than 30 days, which may have increased mortality risk.
被监禁人群获得专科护理的机会可能各不相同，这可能会影响皮肤癌的检测和诊断。
本研究的目的是描述被监禁人群中的皮肤癌特征，并确定活检后开始治疗的时间（TTI）。
采用2009年1月至2019年12月期间一家单中心转诊医院中经活检证实患有基底细胞癌（BCC）、鳞状细胞癌（SCC）或黑色素瘤的被监禁患者的数据进行回顾性队列研究。主要测量的结局是活检后的TTI。
113名患者被诊断和/或治疗了191例皮肤癌，其中大多数为男性（96.5%），白种人（89.4%）。在这191例皮肤癌中，118例为BCC（61.8%），58例为SCC（30.4%），15例为黑色素瘤（7.9%）。黑色素瘤活检后的平均TTI为57天（范围：21 - 136天，中位数：51天，95%置信区间：39.89 - 74.10），平均Breslow深度为1.57毫米。
本研究中被监禁人群黑色素瘤的平均TTI大于30天，这可能增加了死亡风险。
